“Australia's speediest news portal”
One News Page
> >

AstraZeneca ticks another box as U.S. approves severe asthma drug

Reuters Wednesday, 15 November 2017
LONDON (Reuters) - AstraZeneca has achieved another milestone in rebuilding its drug portfolio with U.S. approval of a drug for severe asthma as the company battles to put patent losses on older medicines behind it.
Share on
Share on
Post on 
Share by

You Might Like

Tweets about this

Other recent news in Health

Irish abortion REFERENDUM: Polls closeSheffield STUDENT with cleft lip bullied for the way he looked
YOUTUBE stars 'might encourage kids to eat more calories'Why does CANADA use more human plasma than almost any other country?

Recent related videos

News video: FDA Announces EpiPen Shortage

▶ FDA Announces EpiPen Shortage 01:08

FDA Announces EpiPen Shortage The Food and Drug Administration added the pens to its list of drug shortages on Wednesday. Epinephrine autoinjectors are often used by people who have anaphylactic..
Source: Wibbitz Studio -

News video: CBD Oil Hailed A Miracle Drug For Children With Severe Epilepsy

▶ CBD Oil Hailed A Miracle Drug For Children With Severe Epilepsy 04:52

CBD oil is being hailed a miracle drug for children with severe epilepsy, but under federal law, it's illegal. Juliette Goodrich reports. (5/7/18)
Source: CBS 5 SF KPIX -

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+